Itrapress Eye Drop contains Itraconazole 1% w/v, an antifungal agent belonging to the triazole class, indicated for the treatment of fungal infections of the eye. Itraconazole exerts its therapeutic effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This formulation is primarily used in the management of ocular mycoses caused by susceptible strains of fungi, including Candida, Aspergillus, and Fusarium species. Itrapress Eye Drop is intended for topical ophthalmic use and should be administered as directed by a healthcare professional to ensure optimal efficacy and minimize potential adverse effects. Common side effects may include mild ocular irritation, redness, or a transient burning sensation upon instillation. Patients should avoid contamination of the dropper tip to prevent secondary infections. Caution is advised in individuals with known hypersensitivity to itraconazole or other azole antifungals. The use of Itrapress Eye Drop during pregnancy and lactation should be under strict medical supervision. Proper adherence to prescribed dosage and duration is essential to achieve complete resolution of the infection and prevent recurrence.